2025年神經毒素全球市場報告

預計未來幾年神經毒素市場規模將快速成長，到2029年將達到122.5億美元，複合年成長率為11.2%。預測期內的成長可歸因於神經病學應用的不斷擴展、對美容手術的持續需求、配方創新、消費者意識的提升以及美容旅遊業的蓬勃發展。預測期內的主要趨勢包括藥物傳遞技術的進步、神經毒素開發與研究的合作、市場對神經毒素行業監管變化的反應、神經毒素與多模態治療方案的整合、對持久療效的關注以及患者滿意度。

未來五年的預測成長率為11.2%，較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能會影響美國的美容和神經科醫療實踐，因為愛爾蘭和瑞典生產的肉毒桿菌毒素產品價格上漲，從而提高治療和美容用途的成本。由於互惠關稅以及貿易緊張局勢和限制升級對全球經濟和貿易的負面影響，其影響可能會更加廣泛。

神經毒素市場的預期成長預計將受到旨在改善外觀的整容手術激增的推動。整容手術涵蓋各種醫療介入措施，其主要目的是增強或改變個人的外觀。這一趨勢受到社會、技術和文化因素的影響，以及人們對整容手術益處日益成長的認知。神經毒素透過放鬆某些肌肉，在減少皺紋和細紋的出現方面發揮關鍵作用。例如，美國整形外科醫師協會於2022年8月進行的一項關於整容手術的調查顯示，整容手術的需求顯著增加，美國四分之三的整形外科醫生指出需求有所增加，30% 的外科醫生報告其整容手術業務加倍。旨在改善外觀的整容手術激增是推動神經毒素市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球神經毒素：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球神經毒素市場：成長率分析
• 全球神經毒素市場表現：規模與成長，2019-2024
• 全球神經毒素市場預測：2024-2029年及2034年規模與成長
• 全球神經毒素：總目標市場（TAM）

第6章 市場細分

• 全球神經毒素市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 肉毒桿菌
• Dysport
• Xeomin
• 其他產品
• 全球神經毒素市場：按應用、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 治療
• 美學的
• 全球神經毒素市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 專科診所
• 皮膚科診所
• 其他最終用戶
• 全球神經毒素市場：按肉毒桿菌、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 化妝品用途
• 治療用途
• 全球神經毒素市場：Dysport細分（按類型）、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 化妝品應用
• 醫學指徵
• 全球神經毒素市場： Xeomin細分、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 美容護理
• 治療應用
• 全球神經毒素市場：依產品類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 傑沃
• 新型神經毒素

第7章 區域和國家分析

• 全球神經毒素市場：區域表現與預測，2019-2024 年、2024-2029 年、2034 年
• 全球神經毒素市場：國家、表現與預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 神經毒素市場：競爭格局
• 神經毒素市場：公司簡介
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Galderma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Ipsen SA Overview, Products and Services, Strategy and Financial Analysis
  • Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Supernus Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Merz Pharma GmbH & Co KGaA
• Hugel Inc.
• Evolus Inc.
• Medytox Inc.
• Croma-Pharma GmbH
• Revance Therapeutics Inc.
• US WorldMeds
• Gufic Biosciences Ltd.
• Hironic Co. Ltd.
• Allergan
• List Biological Laboratories
• Lanzhou Institute of Biological Products Co. Ltd.
• Sinclair Pharma
• Vida Aesthetics
• Aquavit Holdings LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年神經毒素市場：提供新機會的國家
• 2029年神經毒素市場：細分市場帶來新機會
• 2029年神經毒素市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

A neurotoxin is a substance that is specifically harmful to nerve cells (neurons) or the nervous system. These toxins function by inhibiting cellular processes within neurons. Neurotoxins are used to temporarily diminish wrinkles by paralyzing certain muscles and to treat conditions such as muscle spasticity, migraines, and excessive sweating. Additionally, they are utilized in research to explore nerve function and the mechanisms of neuronal signaling, contributing to the understanding of neurological disorders.

The primary products classified as neurotoxins include well-known brands such as Botox, Dysport, Xeomin, and others. Botox, derived from the bacteria Clostridium botulinum, is a notable neurotoxin used for both cosmetic and medical purposes. It is employed to temporarily reduce the appearance of wrinkles and to treat certain muscular conditions. These neurotoxin products find applications in therapeutic and aesthetic contexts, with end-users ranging from hospitals and specialty clinics to dermatology clinics and other relevant healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The neurotoxin market research report is one of a series of new reports from The Business Research Company that provides neurotoxin market statistics, including neurotoxin industry global market size, regional shares, competitors with a neurotoxin market share, detailed neurotoxin market segments, market trends and opportunities, and any further data you may need to thrive in the neurotoxin industry. This neurotoxin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotoxin market size has grown strongly in recent years. It will grow from $7.35 billion in 2024 to $8.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to a rise in aesthetic procedures, therapeutic applications, advancements in the cosmetic industry, a growing aging population, and increasing acceptance of non-surgical procedures

The neurotoxin market size is expected to see rapid growth in the next few years. It will grow to $12.25 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expanding applications in neurology, continued demand for aesthetic procedures, innovation in formulations, rising consumer awareness, and expansion of cosmetic tourism. Major trends in the forecast period include advancements in drug delivery techniques, collaborations for neurotoxin development and research, market response to regulatory changes in the neurotoxin industry, integration of neurotoxins in multimodal treatment plans, focus on long-lasting effects, and patient satisfaction.

The forecast of 11.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions may impact U.S. cosmetic and neurology practices by inflating prices of botulinum toxin products manufactured in Ireland and Sweden, resulting in higher costs for both therapeutic and aesthetic applications. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the neurotoxin market is expected to be propelled by the surge in cosmetic procedures aimed at improving appearance. Cosmetic procedures encompass a diverse range of medical interventions undertaken with the primary objective of enhancing or altering an individual's physical appearance. This trend is influenced by societal, technological, and cultural factors, coupled with increased awareness of the benefits associated with cosmetic procedures. Neurotoxins play a crucial role in these procedures by relaxing specific muscles, thereby reducing the appearance of wrinkles and fine lines. For instance, a cosmetic surgery survey by the American Society of Plastic Surgeons in August 2022 revealed a significant increase in demand for cosmetic procedures, with 3 out of 4 plastic surgeons in the USA noting a rise in demand, and 30% reporting a doubling of their cosmetic procedure businesses. This surge in cosmetic procedures to enhance appearance is a key driver fueling the growth of the neurotoxin market.

The increasing aging population is anticipated to drive the growth of the neurotoxin market in the future. The term aging population refers to a demographic trend marked by a rising proportion of elderly individuals within a society or population. This aging demographic often seeks neurotoxin-based treatments, such as Botox, to address age-related cosmetic concerns like wrinkles and facial lines, favoring non-invasive solutions that enhance their appearance and promote a more youthful, rejuvenated look. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, projected that the population of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. During the same period, this age group's share of the overall population is expected to grow from 17% to 23%. Therefore, the growing aging population is driving the expansion of the neurotoxin market.

The innovation of facial aesthetic products is a notable trend gaining popularity in the neurotoxins market, with companies actively engaged in developing and introducing novel products to sustain their positions. One example is Evolus Inc., a US-based medical aesthetics company, which received approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxinA). Nuceiva is a neurotoxin specifically designed for aesthetic purposes, aiming to temporarily enhance the appearance of moderate glabellar lines in adult patients. By blocking nerve impulses to facial muscles, the product induces muscle relaxation, smoothing wrinkles resulting from facial expressions, squinting, and frowning.

Major companies operating in the neurotoxins market are emphasizing innovative products, including facial gel serums, with the goal of enhancing patient satisfaction. An example is the ready-to-use BoNT-A neuromodulator, a pre-formulated and prepared Botulinum Toxin Type A (BoNT-A) product. This product offers a convenient and standardized solution for healthcare practitioners in cosmetic or therapeutic applications. In September 2022, Entod Pharmaceuticals, an Indian-based pharmaceutical company, launched Vasuki, a facial gel serum based on synthetic tripeptide snake venom neurotoxin. The serum is formulated to gently relax muscle contractions under the skin, potentially reducing the appearance of wrinkles and fine lines.

In July 2023, Priveterra Acquisition Corp., a US-based special purpose acquisition company, acquired AEON Biopharma, Inc. for an undisclosed amount. This acquisition aims to create a publicly traded entity focused on advancing AEON's proprietary neurotoxin, ABP-450, which is designed to treat severe conditions such as chronic migraines. The deal intends to utilize up to $125 million in secured funding to support AEON's clinical development and commercialization efforts, thereby strengthening its position in the biopharmaceutical industry and driving growth in the neurosciences market. AEON Biopharma, Inc. is a US-based biopharmaceutical company that produces neurotoxins.

Major companies operating in the neurotoxin market include AbbVie Inc., Galderma Inc., Ipsen SA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals, Merz Pharma GmbH & Co KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., US WorldMeds, Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, List Biological Laboratories, Lanzhou Institute of Biological Products Co. Ltd., Sinclair Pharma, Vida Aesthetics, Aquavit Holdings LLC, PharmaResearch Products Co.Ltd, Entod Pharmaceuticals, Object Pharma Inc.

North America was the largest region in the neurotoxin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotoxin market consists of sales of lead, ethanol (drinking alcohol), glutamate, nitric oxide, tetanus toxin, and tetrodotoxin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotoxin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Botox; Dysport; Xeomin; Other Products
• 2) By Application: Therapeutic; Aesthetic
• 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Subsegments:
• 1) By Botox: Cosmetic Uses; Therapeutic Uses
• 2) By Dysport: Cosmetic Applications; Medical Indications
• 3) By Xeomin: Cosmetic Treatments; Therapeutic Applications
• 4) By Other Products: Jeuveau; Any Emerging Neurotoxins
• Companies Mentioned: AbbVie Inc.; Galderma Inc.; Ipsen SA; Daewoong Pharmaceutical Co. Ltd.; Supernus Pharmaceuticals; Merz Pharma GmbH & Co KGaA; Hugel Inc.; Evolus Inc.; Medytox Inc.; Croma-Pharma GmbH; Revance Therapeutics Inc.; US WorldMeds; Gufic Biosciences Ltd.; Hironic Co. Ltd.; Allergan; List Biological Laboratories; Lanzhou Institute of Biological Products Co. Ltd.; Sinclair Pharma; Vida Aesthetics; Aquavit Holdings LLC; PharmaResearch Products Co.Ltd; Entod Pharmaceuticals; Object Pharma Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurotoxin Market Characteristics

3. Neurotoxin Market Trends And Strategies

4. Neurotoxin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neurotoxin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neurotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neurotoxin Market Growth Rate Analysis
• 5.4. Global Neurotoxin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neurotoxin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neurotoxin Total Addressable Market (TAM)

6. Neurotoxin Market Segmentation

• 6.1. Global Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Botox
• Dysport
• Xeomin
• Other Products
• 6.2. Global Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic
• Aesthetic
• 6.3. Global Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Other End Users
• 6.4. Global Neurotoxin Market, Sub-Segmentation Of Botox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Uses
• Therapeutic Uses
• 6.5. Global Neurotoxin Market, Sub-Segmentation Of Dysport, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Applications
• Medical Indications
• 6.6. Global Neurotoxin Market, Sub-Segmentation Of Xeomin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Treatments
• Therapeutic Applications
• 6.7. Global Neurotoxin Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Jeuveau
• Any Emerging Neurotoxins

7. Neurotoxin Market Regional And Country Analysis

• 7.1. Global Neurotoxin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neurotoxin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurotoxin Market

• 8.1. Asia-Pacific Neurotoxin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurotoxin Market

• 9.1. China Neurotoxin Market Overview
• 9.2. China Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurotoxin Market

• 10.1. India Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurotoxin Market

• 11.1. Japan Neurotoxin Market Overview
• 11.2. Japan Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurotoxin Market

• 12.1. Australia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurotoxin Market

• 13.1. Indonesia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurotoxin Market

• 14.1. South Korea Neurotoxin Market Overview
• 14.2. South Korea Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurotoxin Market

• 15.1. Western Europe Neurotoxin Market Overview
• 15.2. Western Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurotoxin Market

• 16.1. UK Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurotoxin Market

• 17.1. Germany Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurotoxin Market

• 18.1. France Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurotoxin Market

• 19.1. Italy Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurotoxin Market

• 20.1. Spain Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurotoxin Market

• 21.1. Eastern Europe Neurotoxin Market Overview
• 21.2. Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurotoxin Market

• 22.1. Russia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurotoxin Market

• 23.1. North America Neurotoxin Market Overview
• 23.2. North America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurotoxin Market

• 24.1. USA Neurotoxin Market Overview
• 24.2. USA Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurotoxin Market

• 25.1. Canada Neurotoxin Market Overview
• 25.2. Canada Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurotoxin Market

• 26.1. South America Neurotoxin Market Overview
• 26.2. South America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurotoxin Market

• 27.1. Brazil Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurotoxin Market

• 28.1. Middle East Neurotoxin Market Overview
• 28.2. Middle East Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurotoxin Market

• 29.1. Africa Neurotoxin Market Overview
• 29.2. Africa Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurotoxin Market Competitive Landscape And Company Profiles

• 30.1. Neurotoxin Market Competitive Landscape
• 30.2. Neurotoxin Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Galderma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ipsen SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Supernus Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Neurotoxin Market Other Major And Innovative Companies

• 31.1. Merz Pharma GmbH & Co KGaA
• 31.2. Hugel Inc.
• 31.3. Evolus Inc.
• 31.4. Medytox Inc.
• 31.5. Croma-Pharma GmbH
• 31.6. Revance Therapeutics Inc.
• 31.7. US WorldMeds
• 31.8. Gufic Biosciences Ltd.
• 31.9. Hironic Co. Ltd.
• 31.10. Allergan
• 31.11. List Biological Laboratories
• 31.12. Lanzhou Institute of Biological Products Co. Ltd.
• 31.13. Sinclair Pharma
• 31.14. Vida Aesthetics
• 31.15. Aquavit Holdings LLC

32. Global Neurotoxin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurotoxin Market

34. Recent Developments In The Neurotoxin Market

35. Neurotoxin Market High Potential Countries, Segments and Strategies

• 35.1 Neurotoxin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neurotoxin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neurotoxin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer